2024³â ´ëÇѽɳúÇ÷°üÁúȯ¿¹¹æÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-30
±³À°ÀÏÀÚ : 2024-03-30
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» Æĸ£³ª½º ±¹È·ë, ¿ÀÅ°µå·ë
±³À°ÁÖÁ¦ : 2024³â ´ëÇѽɳúÇ÷°üÁúȯ¿¹¹æÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽɳúÇ÷°üÁúȯ¿¹¹æÇÐȸ
´ã´çÀÚ : ¹ÚÇÏ¿¬
¿¬¶ôó : 02-6408-1505
À̸ÞÀÏ : kscpmd@kscpmd.or.kr
±³À°Á¾·ù : ³»°ú, ½Å°æ°ú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ïºñ: (ȸ¿ø)ÀÇ»ç 30,000¿ø, °£È£»ç ¾à»ç ÀÇ·á±â»ç 20,000¿ø (ºñȸ¿ø)ÀÇ»ç 50,000¿ø, °£È£»ç ¾à»ç ÀÇ·á±â»ç 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 09:00~09:20 New drugs and perspectives in the management of hypertension ÀÓ»óÇö(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 09:20~09:40 New drugs for the management of dyslipidemia - recent update and future perspective ±è»óÇö(¼¿ïÀÇ´ë ¼øȯ±â³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 09:40~10:00 New perspectives and future directions in the treatment of heart failure À¯º´¼ö(¿¬¼¼¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 03¿ù 30ÀÏ ±¹È·ë 10:00~10:20 Åä·Ð ()
ÈÞ½Ä 03¿ù 30ÀÏ ±¹È·ë 10:20~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 10:40~11:00 Stroke - Medical Treatment - Lipid Control À¯ÁØ»ó(¿¬¼¼ÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 11:00~11:20 Update of antithrombotics for stroke prevention ¹ÚÈñ±Ç(ÀÎÇÏÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 11:20~11:40 Endovascular treatment of ischemic stroke, from quickening to nowadays ¼ºÀçÈÆ(°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú)
Åä·Ð 03¿ù 30ÀÏ ±¹È·ë 11:40~12:00 Åä·Ð ()
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 12:00~12:20 A paradigm shift in dyslipidemia treatment Á¶¿ëÀÎ(ÀÎÇÏÀÇ´ë ³»ºÐºñ³»°ú)
ÈÞ½Ä 03¿ù 30ÀÏ ±¹È·ë 01:00~01:00 ÈÞ½Ä ()
½Ä»ç 03¿ù 30ÀÏ ±¹È·ë 12:00~13:00 ½Ä»ç ()
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 13:00~13:40 AI in Cerebrovascular Disorders: Enhancing Diagnosis and Treatment ÀÌ°æ¿(¿¬¼¼ÀÇ´ë ½Å°æ°ú)
Åä·Ð 03¿ù 30ÀÏ ±¹È·ë 13:40~14:00 Åä·Ð ()
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 14:00~14:20 Lipoprotein(a) as a residual risk factor for CVD in T2DM °í½ÂÇö(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 14:20~14:40 TG lowering related clinical benefits in T2DM È«ÁØÈ(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 03¿ù 30ÀÏ ±¹È·ë 14:40~15:00 Association between remnant-cholesterol and cardio-renal complications in T2DM ·ùÇýÁø(°í·ÁÀÇ´ë ³»ºÐºñ³»°ú)
Åä·Ð 03¿ù 30ÀÏ ±¹È·ë 15:00~15:20 Åä·Ð ()